Intervention project Osteogenesis Imperfecta (OI) type I and IV: home based training program to increase exercise capacity, muscle strength and aspects of quality of life in children with Osteogenesis Imperfecta

ISRCTN ISRCTN28577651
DOI https://doi.org/10.1186/ISRCTN28577651
Protocol serial number 04/331-k (METC UMCU)
Sponsor University Medical Centre Utrecht (UMCU) (Netherlands)
Funders Johanna Child Fund (Johanna Kinderfonds) (The Netherlands), Foundation for paediatric rehabilitation (Stichting Bio-Kinderrevalidatie) (The Netherlands)
Submission date
20/12/2005
Registration date
20/12/2005
Last edited
19/03/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr R.H.H. Engelbert
Scientific

KB 02.056.0, 3508 AB
P.O. Box 85090
Utrecht
3584 EA
Netherlands

Phone +31 (0)30 2504030
Email r.engelbert@umcutrecht.nl

Study information

Primary study designInterventional
Study designMulticentre, randomised, single-blinded, active controlled, parallel group trial
Secondary study designRandomised controlled trial
Scientific title
Study acronymETOI
Study objectivesChildren with Osteogenesis Imperfecta type I and IV would benefit from a gradual training program. Increased exercise capacity and muscle strength could increase quality of life.
Ethics approval(s)Ethics approval received from the local medical ethics committee
Health condition(s) or problem(s) studiedOsteogenesis Imperfecta
InterventionTraining program for 12 weeks (two times/week).
Intervention typeOther
Primary outcome measure(s)

Exercise capacity and muscle strength.

Key secondary outcome measure(s)

Health related quality of life.

Completion date02/08/2005

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit8 Years
Upper age limit18 Years
SexAll
Target sample size at registration36
Key inclusion criteria1. Osteogenesis Imperfecta Type I and IV
2. Between 8 and 18 years of age
3. Ambulatory
Key exclusion criteria1. Osteogenesis Imperfecta type II and III
2. Retardation
3. Non-walking
Date of first enrolment02/02/2005
Date of final enrolment02/08/2005

Locations

Countries of recruitment

  • Netherlands

Study participating centre

KB 02.056.0, 3508 AB
Utrecht
3584 EA
Netherlands

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/01/2008 Yes No